Netherlands
11 June 2019 - Posted by: Sophie ten Bosch
At the latest meeting of EU agriculture ministers, and following a report by the Danish Council of Ethics, 14 EU member states, led by the Netherlands and Estonia, called for the European Commission to re-evaluate the EU’s stance on genetically modified organisms (GMOs), in particular those created by new plant breeding techniques. In a ruling › Read More
16 May 2019 - Posted by: Francesca Miotto
Last week, the Dutch Authority for Consumers and Markets (ACM) announced that it is investigating whether the Italian pharmaceutical company Leadiant Biosciences restricted the supply of an important raw material for a patented orphan drug, by entering into exclusive agreements with an unnamed supplier. Such supply restrictions for raw materials could, according to the ACM, › Read More
New Dutch Policy rule on the interpretation of “medical device”
08 May 2019 - Posted by: Alex Crespo van de Kooij
The Dutch Health Minister has introduced a Decision setting out a policy rule on the interpretation of the definition of medical device (medisch hulpmiddel), as laid down in the Act on medical devices (Article 1, first paragraph, under a). The Decision was published on 4 April 2019 and entered into effect on the same date. › Read More
Enforcement of upcoming Dutch BIG obligations postponed
20 March 2019 - Posted by: Iradj Nazaryar
The Dutch Inspectorate for Health and Youth Care (IGJ) will not enforce the visible display of the BIG-number by BIG-registered care providers until further notice. The Dutch Ministry of Health, Welfare and Sport indicated it wants a solution for the administrative burdens associated with the revised Dutch Healthcare Professionals Act (Wet BIG) and sufficient time › Read More
Dutch antitrust watchdog publishes additional notification requirements for healthcare mergers
01 March 2019 - Posted by: Iradj Nazaryar
The Dutch Authority for Consumers and Markets (ACM) has published a new method of analysing product markets in merger investigations with respect to specialised medical care. In this context, the ACM requires merging hospitals and independent treatment centres to provide more detailed information in their merger notifications to the ACM. The starting point for the › Read More